Fauci: Early data show omicron spreads quickly but with less severity than delta
By
Alicia Lasek
Dec 08, 2021
Omicron cases appear to have led to fewer hospitalizations and patients have been less likely to need oxygen, the White House’s infectious disease expert said Tuesday.
Clinical briefs for Thursday, Nov. 18
By
Alicia Lasek
Nov 18, 2021
OSHA suspends implementation of COVID-19 vaccine mandate for businesses … Feds expected to OK Pfizer’s COVID vaccine boosters for all adults; Moderna requests the same for its shot … 12 more...
Enrichment activities activate genes that help seniors resist cognitive decline
By
Amy Novotney
Nov 08, 2021
Spending time on intellectually stimulating activities appears to activate a gene family known as MEF2, which controls a genetic program in the brain that promotes resistance to cognitive decline. That’s...
Merck to seek emergency use for COVID-19 antiviral pill that cuts severe outcomes by 50 percent
By
Alicia Lasek
Oct 04, 2021
Molnupiravir has reduced COVID-19 deaths and hospitalizations by half in a new clinical trial. An orally delivered drug could offer unprecedented treatment convenience, the drug’s developers say.
Drugmakers ask FDA to approve another Alzheimer’s drug, similar to Aduhelm
By
Alicia Lasek
Sep 29, 2021
Drugmakers Eisai and Biogen are putting the Food and Drug Administration to the test with a request to approve a second Alzheimer’s drug that works like aducanumab (Aduhelm), the new, yet controversial,...
New CDC vaccine access info covers COVID booster shots, ‘safety net’ support
By
Alicia Lasek
Sep 23, 2021
With assurances to provide help as needed, the Centers of Disease Control and Prevention is sharing vaccine access information ahead of the federal COVID-19 vaccine booster shot approvals expected to come...
CDC: Lasting COVID-19 symptoms tied to age, sex, race factors
By
Alicia Lasek
Sep 21, 2021
Investigators examined recovered COVID-19 patients in Long Beach California. Fully one third of participants reported having at least one symptom of post-acute sequelae, commonly called “long COVID-19,”...
U.S. lawmakers ramp up scrutiny of FDA following agency’s approval of controversial Alzheimer’s drug
By
Alicia Lasek
Sep 07, 2021
The FDA is being asked to help explain how Aduhelm (aducanumab) met accelerated approval criteria when so many experts — including internal advisers — have flagged insufficient safety and efficacy...
Plan your vaccine booster clinics now, LeadingAge entreats LTC operators
By
Alicia Lasek
Aug 25, 2021
With infections now surging in parts of the United States, facility operators can begin taking steps to offer third COVID-19 vaccine doses to eligible staff and residents in anticipation of a federal go-ahead,...
New dashboard to track ‘Long COVID’ cases for healthcare planning
By
Alicia Lasek
Aug 25, 2021
The dashboard will track state and county level statistics and trends. The goal is to provide data to healthcare decision makers as they prepare to care for patients with lingering symptoms, says the American...